4Fujikara K, SuzukiH, McMullen B, et al. Purification of von Wille- brand factor- cleaving protease and its identification as anew member of the metalloproteinase family[J]. Blood, 2001,98:1662-1670.
5Dragon--Durey MA, Fremeaux--BacchiV. A typical haemolytie uraemic syndrome and mutations in complement regulatorgenes [J]. Springer Semin Immunopathol 2005,27:359-374.
6Caprioli J, Bettinaglio P, Zipfel PE. et al. The molecular basis of familial hemoytic Uremic syndrome mutation analysis of factor H gene reveals a hot spot in short consensus repeat[J]. J Am Soc Nephrol, 2001,12 : 297-307.
7Kamali MA,PetricM,LimC. et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin -- producing Escherich coli[J]. J infect Dis, 1985,151:775-782.
9BanatvalaN,Griffin PM,Greene KD. et al. The United States National Progressive Hemolytic Uremic Syndrome Study. microbiologic serologic clinical and epidemiologic findings[J]. J Infect Dis, 2001,183 : 1063- 1070.
10Brandt J,Wong C, Mibm S. et al. Invasive pneumoeoecal diease and hemolytic uremic syndrome. Pediatries. 2002, 110: 371- 376.
二级参考文献39
1Pavord S,kelron JG,Warner MN,et al.Proteolytic degradation of high molecular weight kininogen in acute throm oticthrombocytopenic purpura.Br J Haematol,1997,97:762.
2Ray PE,Liu X-H.Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.Pediatr Nephrol,2001,16:823-839.
4Matsumae T,Takebayashi S,Naito S.The clinico-pathological characteristics and outcome in hemolytic-uremic syndrome of adults.Clin Nephrol,1996,45:153-162.
5Hollenbeck M,Kutkuhn B,Aul C,et al.Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in adults:clinical findings and prognostic factors for death and end-stage renal disease.Nephrol Dial Transplant,1998,13:76-81.
6Tostivint I,Mougenot B,Flahault A,et al.Adult haemolytic and uraemic syndrome:causes and prognostic factors in the last decade,Nephrol Dial Transplant,2002,17:1228-1234.
7Valavaara R,Nordman E.Renal complications of mitomycin C therapy with special reference to the total dose.Cancer,1985,55:47-50.
8Mocan H,Mocan MZ.Postpartum hemolytic uremic syndrome with a more severe liver involvement.Clin Nephrol,1998,49:319-320.
9Renolds JC,Agodoa LY,Yuan CM,et al.Thrombotic microangiopathy after renal transplantation in the United States.Am J Kidney Dis,2003,42:1058-1068.
10Hall S,Glickman M.The british paediatric surveillance unit.Arch Dis Child,1988,63:344-346.
6Kerstin Benz,Kerstin Amann.??Thrombotic microangiopathy: new insights(J)Current Opinion in Nephrology and Hypertension . 2010 (3)
7Dierkes Firuseh,Andriopoulos Nikolaos,Sucker Christoph,Kuhr Kathrin,Hollenbeck Markus,Hetzel Gerd R,Burst Volker,Teschner Sven,Rump Lars C,Benzing Thomas,Grabensee Bernd,Kurschat Christine E.Indicators of acute and persistent renal damage in adult thrombotic microangiopathy. PloS one . 2012
8Peter F Zipfel,Stefan Heinen,Christine Skerka.??Thrombotic microangiopathies: new insights and new challenges(J)Current Opinion in Nephrology and Hypertension . 2010 (4)
